Anti-erbB-2 (Her-2/neu)[4D5-8 (trastuzumab)], Mouse IgG2a
Product Sizes
0.2 mg
£ POA
MBS488872-0.2MG
About this Product
- SKU:
- MBS488872
- Additional Names:
- receptor tyrosine-protein kinase erbB-2 isoform b; Receptor tyrosine-protein kinase erbB-2; receptor tyrosine-protein kinase erbB-2; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2; metastatic lymph node gene 19 protein; tyrosine kinase-type cell surface receptor HER2; neuroblastoma/glioblastoma derived on; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian); Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; Anti-erbB-2 (Her-2/neu)[4D5-8 (trastuzumab)]; CD340; Metastatic lymph node gene 19 protein (MLN 19); Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; p185HER2; EGFR
- Application:
- ELISA, FACS, Flow Cytometry, Immunohistochemistry
- translate.label.attr.clone:
- [4D5-8 (trastuzumab)]
- Concentration:
- 1 mg/ml
- Host:
- Mouse
- Isotype:
- IgG2a, kappa
- Physical State:
- PBS with 0.02% Proclin 300.
- Purity:
- Protein A affinity purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder.
- Storage Conditions:
- Please refer to datasheet
- Supplier:
- MyBioSource
- Type:
- Antibody
- Manufacturer's Data Sheet:MBS488872
